Sector Chart Lineage Cell Therapeutics, Inc.
Stocks
LCTX
US53566P1093
Biotechnology & Medical Research
|
Market Closed -
NYSE
16:00:00 2026-10-16 EDT
|
5-day change | 1st Jan Change | ||
| 0.9783 USD | -1.21% |
|
-1.58% | -41.42% |
| 09-30 | EARNINGS: Generation Essentials interim profit jumps to USD28 million | AN |
| 08-07 | Lineage Cell Therapeutics, Inc., Q2 2026 Earnings Call, Aug 06, 2026 |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Other Biotechnology & Medical Research
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 247M | - | - | - | ||
| 65B | |||||
| 51.2B | |||||
| 51.19B | |||||
| 43.93B | |||||
| 41.96B |
Select your edition
All financial news and data tailored to specific country editions
